MFN2 mutations are also associated with many other conditions, such as Alzheimer’s disease, Parkinson’s disease, obesity, and diabetes (Kim et al., 2017; Wang et al., 2009; Lee et al., 2012; Bach et al., 2003). This evidence concerns the gene MFN2 and early-onset autosomal dominant Alzheimer disease.